Occudo Quantitative Strategies LP Takes $1.06 Million Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Occudo Quantitative Strategies LP acquired a new position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) in the 4th quarter, Holdings Channel reports. The fund acquired 2,038 shares of the medical equipment provider’s stock, valued at approximately $1,064,000.

A number of other hedge funds have also modified their holdings of ISRG. Norges Bank acquired a new position in Intuitive Surgical during the 4th quarter worth approximately $2,401,493,000. Proficio Capital Partners LLC lifted its position in shares of Intuitive Surgical by 89,098.8% in the fourth quarter. Proficio Capital Partners LLC now owns 949,967 shares of the medical equipment provider’s stock worth $495,845,000 after purchasing an additional 948,902 shares in the last quarter. Capital Research Global Investors boosted its holdings in Intuitive Surgical by 25.5% during the fourth quarter. Capital Research Global Investors now owns 3,381,302 shares of the medical equipment provider’s stock worth $1,764,904,000 after purchasing an additional 687,906 shares during the last quarter. Raymond James Financial Inc. bought a new position in shares of Intuitive Surgical in the 4th quarter valued at about $313,769,000. Finally, Northern Trust Corp increased its position in shares of Intuitive Surgical by 15.8% in the fourth quarter. Northern Trust Corp now owns 3,619,293 shares of the medical equipment provider’s stock valued at $1,889,126,000 after acquiring an additional 494,496 shares during the last quarter. 83.64% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

Several brokerages recently commented on ISRG. Jefferies Financial Group increased their price target on Intuitive Surgical from $475.00 to $575.00 in a research report on Monday, January 27th. Piper Sandler cut their price objective on Intuitive Surgical from $670.00 to $575.00 and set an “overweight” rating for the company in a report on Wednesday, April 23rd. Bernstein Bank boosted their target price on shares of Intuitive Surgical from $655.00 to $700.00 and gave the stock an “overweight” rating in a report on Monday, January 27th. Evercore ISI dropped their price target on shares of Intuitive Surgical from $510.00 to $470.00 and set an “in-line” rating on the stock in a research report on Wednesday, April 23rd. Finally, Wells Fargo & Company lifted their price objective on shares of Intuitive Surgical from $630.00 to $687.00 and gave the company an “overweight” rating in a research report on Friday, January 24th. Five investment analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the company’s stock. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus price target of $598.95.

Insiders Place Their Bets

In other Intuitive Surgical news, CFO Jamie Samath sold 188 shares of Intuitive Surgical stock in a transaction dated Friday, February 28th. The shares were sold at an average price of $566.94, for a total value of $106,584.72. Following the completion of the sale, the chief financial officer now owns 7,162 shares in the company, valued at $4,060,424.28. The trade was a 2.56% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, VP Fredrik Widman sold 810 shares of the firm’s stock in a transaction that occurred on Monday, March 3rd. The stock was sold at an average price of $573.78, for a total transaction of $464,761.80. Following the transaction, the vice president now directly owns 473 shares in the company, valued at $271,397.94. This represents a 63.13% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 32,636 shares of company stock worth $16,829,815 in the last 90 days. Company insiders own 0.70% of the company’s stock.

Intuitive Surgical Stock Up 0.4%

Intuitive Surgical stock opened at $563.95 on Wednesday. The company’s 50-day moving average price is $501.31 and its two-hundred day moving average price is $535.58. The stock has a market cap of $202.13 billion, a P/E ratio of 87.98, a P/E/G ratio of 5.85 and a beta of 1.70. Intuitive Surgical, Inc. has a twelve month low of $379.67 and a twelve month high of $616.00.

Intuitive Surgical (NASDAQ:ISRG) last announced its earnings results on Tuesday, April 22nd. The medical equipment provider reported $1.81 earnings per share for the quarter, topping analysts’ consensus estimates of $1.71 by $0.10. The company had revenue of $2.25 billion for the quarter, compared to analyst estimates of $2.19 billion. Intuitive Surgical had a return on equity of 14.55% and a net margin of 27.81%. During the same quarter last year, the company earned $1.50 earnings per share. Equities analysts anticipate that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current fiscal year.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.